Intuitive Surgical Aktie 1631646 / US46120E6023
545.10
USD
2.98
USD
0.55%
17.12.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Intuitive Surgical Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2022 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2021 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2020 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2019 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2018 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2017 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2016 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2015 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
| 2014 | Intuitive Surgical Inc | 0.00 | 0.00 | USD |
Gewinn je Aktie- Intuitive Surgical
| 5.0 23 | 3.6 22 | 4.7 21 | 2.9 20 | 3.8 19 | 3.2 18 | 1.9 17 |
Umsatz je Aktie- Intuitive Surgical
| 19.9 23 | 17.2 22 | 15.6 21 | 12.1 20 | 12.5 19 | 10.4 18 | 9.0 17 |
KGV- Intuitive Surgical
| 67.1 23 | 72.6 22 | 77.1 21 | 92.8 20 | 51.2 19 | 50.4 18 | 64.3 17 |
Intuitive Surgical Inc: Die Aktie (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 |
| Gewinn je Aktie unverwässert | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 |
| Gewinn je Aktie verwässert | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 |
| Dividende pro Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gesamtdividendenausschüttung in Mio. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intuitive Surgical Inc: Unternehmenskennzahlen (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 19.93 | 17.19 | 15.61 | 12.08 | 12.49 | 10.45 | 8.98 |
| KGV (Jahresendkurs, EPS unverwässert) | 67.06 | 72.64 | 77.10 | 92.79 | 51.22 | 50.44 | 64.31 |
| KGV (Jahresendkurs, EPS verwässert) | 67.06 | 72.64 | 77.10 | 92.79 | 51.22 | 50.44 | 64.31 |
| KGV (Jahresendkurs) | 67.06 | 72.64 | 77.10 | 92.79 | 51.22 | 50.44 | 64.31 |
| Dividendenrendite Jahresende in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Eigenkapitalquote in % | 86.30 | 85.65 | 88.17 | 87.38 | 85.12 | 85.23 | 82.09 |
| Fremdkapitalquote in % | 13.70 | 14.35 | 11.83 | 12.62 | 14.88 | 14.77 | 17.91 |
Intuitive Surgical Inc: GuV (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 7’124.10 | 6’222.20 | 5’710.10 | 4’358.40 | 4’478.50 | 3’724.20 | 3’131.80 |
| Umsatzveränderung in % | 14.49 | 8.97 | 31.01 | -2.68 | 20.25 | 18.92 | 15.84 |
| Bruttoergebnis vom Umsatz | 4’729.50 | 4’187.40 | 3’940.10 | 2’838.50 | 3’098.70 | 2’596.00 | 2’197.30 |
| Bruttoergebnisveränderung in % | 12.95 | 6.28 | 38.81 | -8.40 | 19.36 | 18.14 | 16.95 |
| Operatives Ergebnis | 1’766.80 | 1’577.10 | 1’821.00 | 1’048.60 | 1’375.00 | 1’244.60 | 1’082.80 |
| Veränderung Operatives Ergebnis in % | 12.03 | -13.39 | 73.66 | -23.74 | 10.48 | 14.94 | 13.22 |
| Ergebnis vor Steuern | 1’958.90 | 1’606.80 | 1’890.30 | 1’207.00 | 1’502.20 | 1’279.50 | 1’096.50 |
| Veränderung Ergebnis vor Steuern in % | 21.91 | -15.00 | 56.61 | -19.65 | 17.41 | 16.69 | 11.80 |
| Ergebnis nach Steuer | 1’798.00 | 1’322.30 | 1’704.60 | 1’060.60 | 1’379.30 | 1’127.90 | 660.00 |
| Veränderung Ergebnis nach Steuer in % | 35.98 | -22.43 | 60.72 | -23.11 | 22.29 | 70.89 | -10.31 |
Intuitive Surgical Inc: Bilanz (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 2’126 | 1’861 | 1’604 | 1’410 | 1’449 | 1’159 | 1’031 |
| Langzeit Gesamtverbindlichk. pro Aktie | 1.33 | 1.26 | 1.27 | 1.26 | 1.20 | 0.99 | 0.97 |
| Eigenkapital | 13’397 | 11’113 | 11’952 | 9’759 | 8’285 | 6’688 | 4’727 |
| Veränderung Eigenkapital in % | 20.52 | -7.22 | 22.29 | 17.76 | 23.73 | 41.34 | -18.22 |
| Bilanzsumme | 15’524 | 12’974 | 13’555 | 11’169 | 9’733 | 7’847 | 5’758 |
| Veränderung Bilanzsumme in % | 19.65 | -4.29 | 21.36 | 14.75 | 24.04 | 36.27 | -11.24 |
Intuitive Surgical Inc: Sonstige Angaben (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 37.72 | -22.34 | 58.42 | -24.16 | 20.49 | 67.88 | -7.72 |
| Gewinn je Aktie (verwässert) | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 |
| Veränderung Gewinn je Aktie (verwässert) in % | 37.72 | -21.61 | 58.56 | -23.62 | 21.57 | 67.29 | -9.10 |
| Anzahl Mitarbeiter | 13’676 | 12’120 | 9’793 | 8’081 | 7’326 | 5’527 | 4’444 |
| Veränderung Anzahl Mitarbeiter in % | 12.84 | 23.76 | 21.19 | 10.31 | 32.55 | 24.37 | 18.35 |
Intuitive Surgical Inc Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Intuitive Surgical Inc | Quartalszahlen | 23.01.2025 |
| Intuitive Surgical Inc | Quartalszahlen | 17.04.2025 |
| Intuitive Surgical Inc | Quartalszahlen | 17.07.2025 |
| Intuitive Surgical Inc | Quartalszahlen | 16.10.2025 |
Intuitive Surgical Inc vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 17.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 18.07.2024 |
| Hauptversammlung | Annual General Meeting | 25.04.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 18.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 23.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 19.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 20.07.2023 |
| Hauptversammlung | Annual General Meeting | 27.04.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 18.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 24.01.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 18.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 21.07.2022 |
| Hauptversammlung | Annual General Meeting | 28.04.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 21.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 20.01.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.39 |
| The Vanguard Group, Inc. | 8.53 |
| Vanguard Group, Inc. (Subfiler) | 8.49 |
| T. Rowe Price Associates, Inc. (IM) | 4.77 |
| State Street Corp. | 4.23 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 3.96 |
| Vanguard Total Stock Market ETF | 3.15 |
| BlackRock Fund Advisors | 2.88 |
| Vanguard 500 Index Fund | 2.64 |
| Fidelity Management & Research Co. LLC | 2.22 |
| BlackRock Institutional Trust Co. NA | 2.20 |
| Geode Capital Management LLC | 2.11 |
| Capital Research & Management Co. (World Investors) | 2.08 |
| JPMorgan Investment Management, Inc. | 1.99 |
| Invesco QQQ Trust | 1.98 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 4’444 | 5’527 | 7’326 | 8’081 | 9’793 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.70 | 0.67 | 0.61 | 0.54 | 0.58 |
Bilanz (in Mio. USD) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 2’811 | 4’333 | 4’663 | 6’626 | 5’845 |
| Summe Anlagevermögen | 2’947 | 3’514 | 5’071 | 4’543 | 7’710 |
| Summe Aktiva | 5’758 | 7’847 | 9’733 | 11’169 | 13’555 |
Bilanz (in Mio. USD) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1’031 | 1’159 | 1’449 | 1’410 | 1’604 |
| Summe Eigenkapital | 4’727 | 6’688 | 8’285 | 9’759 | 11’952 |
| Summe Passiva | 5’758 | 7’847 | 9’733 | 11’169 | 13’555 |
Adresse
| 1020 Kifer Road, 94086-5304 Sunnyvale | |
| Telefon | +1 (408) 523-2100 |
| URL | http://www.intuitive.com |
Management
|
Amal M. Johnson
Independent Director |
|
Amy L. Ladd
Independent Director |
|
Brian E. Miller
Chief Digital Officer & Executive Vice President |
|
Calvin Darling
Senior Director-Finance & Investor Relations |
|
Christopher R. Carlson
EVP-Research & Corporate Development |
|
Craig H. Barratt
Chairman |
|
Darla Hutton
VP-Asia Commercial Operations & Marketing |
|
David J. Rosa
President & Director |
|
Fredrik Widman
Principal Accounting Officer, VP & Controller |
|
Gary H. Loeb
Chief Compliance Officer & General Counsel |
|
Gary S. Guthart
Chief Executive Officer & Director |
|
Glenn Vavoso
Senior Vice President & President-Asia Pacific |
|
Henry L. Charlton
SVP, Chief Commercial & Marketing Officer |
|
Ian Purdy
Senior Vice President-Regulatory & Quality Affairs |
|
Jami K. Dover Nachtsheim
Independent Director |
|
Jamie E. Samath
Chief Financial Officer & Senior Vice President |
|
Joseph C. Beery
Independent Director |
|
Kara Andersen Reiter
Senior VP-Litigation, Privacy & Employment Law |
|
Keith R. Leonard
Independent Director |
|
Lewis Chew
Director |
|
Mark J. Rubash
Independent Director |
|
Mark P. Brosius
SVP, Chief Manufacturing & Supply Chain Officer |
|
Marshall L. Mohr
Executive Vice President-Global Business Services |
|
Monica P. Reed
Independent Director |
|
Myriam J. Curet
Chief Medical Officer & Executive Vice President |
|
Patricia L. Wadors
Chief Human Resources Officer |
|
Robert DeSantis
EVP, Chief Strategy & Corporate Operations Officer |
|
Sreelakshmi Kolli
Director |